X
X

Dr. Shruti Kate

   MBBS, MD (Internal Medicine), DM (Medical Oncology)

Book An Appointment

Home / Doctors / Dr. Shruti Kate

Dr. Shruti Kate

  Qualification

MBBS, MD (Internal Medicine), DM (Medical Oncology)

  Specialities

Medical Oncology
Haematology and Bone Marrow Transplant

  Locations

HCG Manavata Cancer Centre - Nasik

  Experience

13 Years

Introduction
Expertise
  • Dr. Shruti’s major areas of interest include gynaecological cancers, genitourinary cancers, thoracic cancers, gastrointestinal cancers and haematological malignancies.
  • She has 6 years of experience and is experienced in treating all solid tumours, paediatric tumours, and haematological malignancies.
  • Dr. Shruti has a special interest in immunotherapy and metronomic therapy for the treatment of advanced cancers. 
  • So far, she has handled more than 50,000 cases.
Recognition
  • Dr. Shruti is a member of several reputed national & international oncological societies, such as ASCO, ESMO, IASLC, ISMPO, and IOS.
  • She has presented her research on lung cancer in the World Conference on Lung Cancer (WCLC) in Toronto, Canada, and was the sole recipient of a travel award from India in WCLC 2018.
Publications
  • Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. Lung Cancer (Auckl). 2019 Jan 29;10:1-10.
  • Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study. Cancer Treat Res Commun. 2021;26:100280.
  • Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience. Eur J Breast Health. 2020 Dec 24;17(1):62-67.
  • A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies. J Pediatr Hematol Oncol. 2020 May;42(4):e202-e206.
  • Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. Ecancermedicalscience. 2018 Oct 9;12:876.

   Practices at

Other Doctors

HCG Call Icon